Literature DB >> 2254461

Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin.

T A Waldmann1, W D Terry.   

Abstract

The metabolism of albumin and IgG was investigated in two siblings, products of a first-cousin marriage, a female aged 34 yr and a male aged 17, who had a marked reduction in their respective serum concentrations of IgG (1.3 and 3.1 mg/ml) and albumin (19 and 21 mg/ml). The metabolism of radioiodinated IgG and albumin was studied in the two patients. The total circulating and body pools of IgG were less than 28% of normal. The IgG synthetic rates were within the normal range. However, the IgG survival was short, with their respective fractional catabolic rates increased fivefold to 31% and 36% of the intravenous pool per day (normal, 6.7 +/- 2%/d). Furthermore, the patients had reduced total body pools, normal synthetic rates, and increased fractional catabolic rates for albumin. There was no proteinuria or abnormality of renal or liver function. In addition, the patients did not have circulating antibodies directed toward IgG, IgA, or albumin. Furthermore, both patients had normal fecal 51Cr-labeled albumin tests, thus excluding excessive gastrointestinal protein loss. We propose that these siblings have a previously unrecognized familial disorder characterized by reduced serum concentrations of IgG and albumin caused by a defect in endogenous catabolism, leading to a short survival of these proteins that is associated in this family with chemical diabetes and a skeletal deformity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254461      PMCID: PMC329849          DOI: 10.1172/JCI114947

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  Gastrointestinal protein loss demonstrated by Cr-51-labelled albumin.

Authors:  T A WALDMANN
Journal:  Lancet       Date:  1961-07-15       Impact factor: 79.321

3.  The role of the gastrointestinal system in "idiopathic hypoproteinemia".

Authors:  T A WALDMANN; J L STEINFELD; T F DUTCHER; J D DAVIDSON; R S GORDON
Journal:  Gastroenterology       Date:  1961-09       Impact factor: 22.682

4.  The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition.

Authors:  R M Blaese; W Strober; R S Brown; T A Waldmann
Journal:  Lancet       Date:  1968-05-18       Impact factor: 79.321

Review 5.  Metabolism of immunoglobulins.

Authors:  T A Waldmann; W Strober
Journal:  Prog Allergy       Date:  1969

Review 6.  Protein-losing enteropathy.

Authors:  T A Waldmann
Journal:  Gastroenterology       Date:  1966-03       Impact factor: 22.682

7.  Direct measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein loss.

Authors:  R D Wochner; S M Weissman; T A Waldmann; D Houston; N I Berlin
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

8.  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism.

Authors:  R D Wochner; G Drews; W Strober; T A Waldmann
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

9.  Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism.

Authors:  R M Blaese; W Strober; A L Levy; T A Waldmann
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

10.  Hypercatabolism of normal IgG; an unexplained immunoglobulin abnormality in the connective tissue diseases.

Authors:  R D Wochner
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  34 in total

1.  Proteus syndrome and immunodeficiency.

Authors:  D Hodge; S A Misbah; R F Mueller; E J Glass; P A Chetcuti
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

2.  Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model.

Authors:  Jonghan Kim; William L Hayton; John M Robinson; Clark L Anderson
Journal:  Clin Immunol       Date:  2006-10-13       Impact factor: 3.969

Review 3.  Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn.

Authors:  Kristi Baker; Shuo-Wang Qiao; Timothy Kuo; Kanna Kobayashi; Masaru Yoshida; Wayne I Lencer; Richard S Blumberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

4.  Effects of the FcRn developmental pharmacology on the pharmacokinetics of therapeutic monoclonal IgG antibody in pediatric subjects using minimal physiologically-based pharmacokinetic modelling.

Authors:  Deni Hardiansyah; Chee Meng Ng
Journal:  MAbs       Date:  2018-07-30       Impact factor: 5.857

Review 5.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

6.  Cross-species/cross-modality physiologically based pharmacokinetics for biologics: 89Zr-labelled albumin-binding domain antibody GSK3128349 in humans.

Authors:  Armin Sepp; Mats Bergström; Marie Davies
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

7.  Impact of altered endogenous IgG on unspecific mAb clearance.

Authors:  Saskia Fuhrmann; Charlotte Kloft; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-04-24       Impact factor: 2.745

8.  A Minimal Physiologically Based Pharmacokinetic Model with a Nested Endosome Compartment for Novel Engineered Antibodies.

Authors:  Dongfen Yuan; Frederik Rode; Yanguang Cao
Journal:  AAPS J       Date:  2018-03-14       Impact factor: 4.009

9.  Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding.

Authors:  Jan Terje Andersen; Muluneh Bekele Daba; Gøril Berntzen; Terje E Michaelsen; Inger Sandlie
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

10.  Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn.

Authors:  Adam R Mezo; Kevin A McDonnell; Cristina A Tan Hehir; Susan C Low; Vito J Palombella; James M Stattel; George D Kamphaus; Cara Fraley; Yixia Zhang; Jennifer A Dumont; Alan J Bitonti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.